Biotech / MedTech
Merck expands biosafety testing laboratory in Singapore to strengthen services across Asia Pacific
Merck, a global science and technology company, is expanding its Singapore lab to further strengthen analytical and biosafety testing services for customers across the Asia Pacific region.
Singapore’s Tikva Allocell raises $8M in Series A financing led by Kantharos Capital
Tikva Allocell Pte. Ltd. (Tikva), a Singapore-based biotechnology company, has on Wednesday announced the closing of an $8 million Series A financing led by Kantharos Capital.
Singapore’s AngelCentral backs US biotech firm Rybodyn
Singapore-based investor AngelCentral announced Wednesday its first successful BioTech syndicate by its members to invest in RyboDyn Inc., a US biotechnology company pioneering the development of immunotherapies targeting the dark genome.
Singapore’s ChemT Biotechnology raises $4M seed round to build AI intelligence layer for biomanufacturing
ChemT Biotechnology, an AI-driven biotechnology company based on Singapore, has closed a $4 million seed round led by Wavemaker Ventures and co-investment partner SEEDS, an arm of SG Growth Capital, with support from Wavemaker 360 Health, Draper University Ventures, and Temasek Life Sciences Accelerator.
Melazyme raises $2M seed round from Thailand-based SeaX to scale precision fermentation platform
Melazyme, a precision fermentation startup focused on functional biomolecules, has raised $2 million in a seed funding round led by SeaX Ventures, with participation from Stellaris Venture Partners and Plug and Play Ventures.
Wavemaker Impact leads $700K pre-seed investment in Singapore’s Virdalis
Virdalis, a Singapore-based biotechnology company developing protein from Wolffia globosa—commonly known as duckweed—has secured US$700,000 in pre-seed funding led by Wavemaker Impact.
Gobi Partners invests in Cortical Labs, expands biological computing hub
Asia-focused venture capital firm Gobi Partners has invested in Cortical Labs, a biotechnology company developing computing systems that combine living human neurons with silicon hardware.
Malaysia’s Bioeconomy Corp eyes $540M revenue in 2026
The Malaysian Bioeconomy Development Corporation (Bioeconomy Corporation) is eyeing MYR 2.2 billion ($540 million) of revenue in 2026.
Temasek-backed D3 Bio secures $108M in Series B financing to advance global clinical programs
D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, has announced the completion of a $108 million Series B financing round.
Singapore’s Bioactivx raises $1.43M in seed round led by Cocoon Capital
Bioactivx (BAX), a Singapore-based biomaterials startup, has closed its $1.43 million seed funding round led by Cocoon Capital, with participation from global strategic investors.
